Drug Class: Bacterial vaccines
2 months to 5 years:
4 dose series:
3 primary doses of 0.5 mL, IM, at 2, 4 and 6 months of age
1 booster dose of 0.5 mL, IM, at 15 to 18 months of age
Data not available
Data not available
Safety and efficacy have not been established in patients younger than 6 weeks.
To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov
Consult WARNINGS section for additional precautions.
Data not available
Administration advice: